Charles River Laboratorie...

NYSE: CRL · Real-Time Price · USD
136.84
1.24 (0.91%)
At close: May 23, 2025, 3:59 PM
140.50
2.67%
After-hours: May 23, 2025, 05:29 PM EDT
0.91%
Bid 136
Market Cap 6.72B
Revenue (ttm) 4.02B
Net Income (ttm) -31.56M
EPS (ttm) -0.61
PE Ratio (ttm) -224.34
Forward PE 13.16
Analyst Hold
Ask 140.5
Volume 395,730
Avg. Volume (20D) 1,772,050
Open 134.21
Previous Close 135.60
Day's Range 133.85 - 137.00
52-Week Range 91.86 - 254.15
Beta 1.50

About CRL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for CRL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 weeks ago
+18.68%
Charles River shares are trading higher after the ... Unlock content with Pro Subscription
1 month ago
-28.13%
Charles River Laboratories shares are trading higher. The stock may be moving up after the FDA stated plans to phase out animal testing requirements for monoclonal antibodies and other drugs.